Search

Your search keyword '"Lanctôt, Krista L."' showing total 374 results

Search Constraints

Start Over You searched for: Author "Lanctôt, Krista L." Remove constraint Author: "Lanctôt, Krista L." Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
374 results on '"Lanctôt, Krista L."'

Search Results

1. Neurophysiological and other features of working memory in older adults at risk for dementia

3. Soluble Epoxide Hydrolase Derived Linoleic Acid Oxylipins, Small Vessel Disease Markers, and Neurodegeneration in Stroke

8. Adverse effects of methylphenidate for apathy in patients with Alzheimer's disease (ADMET2 trial)

19. Time setting errors in the Clock Drawing Test are associated with both semantic and executive deficits.

22. Relationships of change in Clinical Dementia Rating (CDR) on patient outcomes and probability of progression: observational analysis

25. Reduction of agitation and caregiver distress using a combination intervention of tetrahydrocannabinol and melatonin in dementia due to Alzheimer disease

27. Investigating the effects of aerobic exercise primed anodal transcranial direct current stimulation on γ‐aminobutyric acid concentrations in mild vascular cognitive impairment

28. Beta to Theta Power Ratio in Electroencephalogram Periodic Components to Discriminate Mild Cognitive Impairment and Alzheimer’s Dementia

32. Reduction of neuropsychiatric symptoms and associated caregiver distress using a tetrahydrocannabinol and melatonin combination in dementia due to Alzheimer’s disease

34. Investigating the impact of hypertension with and without diabetes on progression to Alzheimer’s disease: A clinic‐pathological study

35. Effect of tetrahydrocannabinol and melatonin combination on suicide ideation and behavior in dementia due to Alzheimer’s disease

36. Risk of motor vehicle collisions and culpability among older drivers using cannabis: a meta‐analysis

38. Reduction of apathy and caregiver distress using a combination of tetrahydrocannabinol and melatonin in dementia due to Alzheimer’s disease

39. Associations between homocysteine, tau, and neurodegenerative markers in apolipoprotein ε4 non‐carriers with clinical Alzheimer’s disease

40. Mapping of validated apathy scales onto the apathy diagnostic criteria for neurocognitive disorders

41. Effect of the combination of tetrahydrocannabinol and melatonin (IGC‐AD1) on blood pressure variability in patients with mild to moderate Alzheimer’s Disease

42. Blood‐based biomarkers for predicting treatment response in the Apathy in Dementia Methylphenidate Trial 2 randomized clinical trial

43. Circulating cell‐free mitochondrial DNA (ccf‐mtDNA) and memory in mild cognitive impairment (MCI) and Alzheimer’s disease (AD)

44. Association between lipopolysaccharide, immune biomarkers and cerebral amyloid‐beta deposition in older adults with mild cognitive impairment & major depressive disorder

46. Cognitive function based on theta-gamma coupling vs. clinical diagnosis in older adults with mild cognitive impairment with or without major depressive disorder.

47. Exercise priming with transcranial direct current stimulation: a study protocol for a randomized, parallel-design, sham-controlled trial in mild cognitive impairment and Alzheimer’s disease

Catalog

Books, media, physical & digital resources